Liver Transplantation in EHPVO: Rarely Indicated
Liver transplantation is NOT a standard indication for extrahepatic portal venous obstruction (EHPVO), as the native liver parenchyma remains functionally normal in the vast majority of patients. 1, 2
When to Consider Liver Transplantation in EHPVO
Transplantation should only be considered in the exceptional circumstance of secondary biliary cirrhosis with decompensated liver failure resulting from long-standing, untreated portal cavernoma cholangiopathy (PCC). 1
Specific Indications (Extremely Rare):
Primary indication:
- Secondary biliary cirrhosis with hepatic decompensation from chronic biliary obstruction due to PCC that has failed all other interventions 1
This represents a vanishingly small subset of EHPVO patients, as:
- Most patients respond to endoscopic or surgical biliary decompression 1
- Progressive liver failure from PCC is rarely seen 1
- The native liver parenchyma is typically preserved in EHPVO 2
Why EHPVO is NOT a Transplant Indication
Critical distinction: EHPVO is fundamentally different from cirrhotic portal hypertension. The liver itself is normal—only the portal venous system is obstructed. 3, 2
Standard Management Hierarchy (NOT Transplantation):
- Endoscopic therapy for variceal bleeding (first-line)
- Surgical portosystemic shunts (meso-Rex bypass, proximal splenorenal shunt) 4, 5
- Endovascular interventions (portal vein recanalization, TIPS, TEPS) 6, 4
- Biliary interventions for portal cavernoma cholangiopathy 1
These interventions are successful in the vast majority of patients, making transplantation unnecessary. 1
Technical Considerations IF Transplantation Required
When secondary biliary cirrhosis necessitates transplantation, deceased donor liver transplantation is strongly preferred over living donor transplantation because: 1
- EHPVO is typically non-emergent
- Establishing portal inflow is technically challenging due to cavernomatous transformation
- Portal blood flow can be achieved through:
- Conduit to small patent portal vein segment
- Direct anastomosis to cavernoma vessels
- No need to risk a living donor for this complex reconstruction
Technical Challenge:
The portal cavernoma that caused the biliary obstruction becomes the primary surgical obstacle during transplantation, making vascular reconstruction difficult. 1
Common Pitfall to Avoid
Do not refer EHPVO patients for transplant evaluation based solely on:
- Recurrent variceal bleeding
- Hypersplenism
- Portal biliopathy without cirrhosis
- Portal vein thrombosis alone
These complications should be managed with endoscopic, surgical shunt, or endovascular techniques—NOT transplantation. 2, 4
The key decision point: Has the patient developed true secondary biliary cirrhosis with hepatic decompensation (ascites, encephalopathy, synthetic dysfunction) that is refractory to biliary decompression? Only then does transplantation enter consideration.
In contrast, the older British Society of Gastroenterology guidelines [@2-10@] list portal venous system thrombosis as only a relative contraindication requiring assessment at a transplant center—not as an indication itself. This reflects that portal vein thrombosis complicates transplantation but doesn't justify it in the absence of underlying liver disease.